USA - NASDAQ:QNTM - CA74764Y2050 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to QNTM. The Buy consensus is the weighted average rating of the current analysts ratings.
7 analysts have analysed QNTM and the average price target is 33.77 USD. This implies a price increase of 142.97% is expected in the next year compared to the current price of 13.9.
The consensus rating for QUANTUM BIOPHARMA LTD (QNTM) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.